glp-1 agonist clinical trials receptor agonists and cardiovascular outcome trials: An update GLP-1 receptor agonists and acute

Additional insights come from studies exploring profound immune dysregulation

S kt hp ca 2 thnh phn gip dng trng, chng lo ha, gip da rng r cng mn Cng thc dng da lnh tnh, ph hp vi mi loi da, khng gy kch ng Sn phm ph hp vi mi loi da Ngoi tc dng dng trng, nng tng da, kem cn gip gi m, se kht l chn lng v lm cng bng da

ConradCLympJThompsonVDunnCDaviesZChatfieldBet al

The Amide Advantage Nacuitys refined, prescription-quality amide, NPI-001, has consequential properties for central nervous system use

G.HouseC

Foundational Discovery Selective Senolytic Elimination in Aged Mice (Cell, 2017 Baar et al.) FOXO4-DRI Restores Fitness, Fur Density, Renal and Liver Function in Aged Mice The foundational study introducing FOXO4-DRI as a senolytic peptide was published in Cell by Baar and colleagues in 2017